Eric Lefkofsky is Disrupting the Treatment of Cancer

Eric Lefkofsky is a serial entrepreneur whose most recent startup, Tempus, holds the promise of vastly improving treatment for people with cancer, according to a recent article in Tech News Spy.

In 2014, 14.5 million Americans lived with cancer, according to an estimate of the National Cancer Institute. By 2024, estimates expect to rise to 19 million. At the disease’s current rates, 40% of Americans will eventually get it.

A few years ago, Eric Lefkofsky’s wife received a diagnosis of breast cancer. That’s when he learned modern medicine, despite many advances in research and in using technology to keep medical records, still did not effectively use digital technology to collect and store data on disease.

Doctors and medical treatment facilities create large amounts of data on cancer patients, but not in a form that is easily accessible so that it can be used to study the effectiveness of disease. For example, much important information about each patient is buried in freeform text fields in the physician notes or progress notes.

Determined to change that, Lefkofsky co founded Tempus to create a platform to record and store information in a standard format and database.

One increasingly important type of patient information is genomic, the sequencing of their unique DNA. Since 2003, the price of gene sequencing has fallen from $300 million to $5,000. And increased demand will continue to drive it down. Modern cancer medicine believes the key to defeating cancer lies in chemotherapy that is configured to suit each patient’s cancer’s genomic structure. The precision medicine enabled by Tempus will allow doctors to fight every cancer based on data. Doctors will be able to access this information so they can prescribe individualized treatments for each patient.

Eric Lefkofsky graduated from University of Michigan Law School in 1993, but has avoided practicing as a lawyer. After he completed law school, he and a friend started Brandon Apparel. By 1999, he and his friend joined the early Internet fervor, founding Starbelly to learn more: https://www.insidephilanthropy.com/guide-to-individual-donors/eric-lefkofsky.html click here.

Lefkofsky went on to many other ventures, including Lightbank, InnerWorkings, Echo Global Logistics and MediaBank. His most well-known venture, however, is Groupon, where he is still Chairman.

Eric Lefkofsky Brings Change to Medical World With Tempus

Eric Lefkofsky first kickstarted his career with the public releases of companies InnerWorkings and Echo Global Logistics. While these are not widely known to the public, you probably are familiar with Groupon, his other company. Through these startups, Eric has already generated $1.79 billion and is set to bring in even more money as the years go on. He is continually looking to improve and scouting for new business opportunities.

More recently he and his partner Brad Keywell released an intricate genomic database for cancer called Tempus. This company has high goals and is meant for doctors to use in order to compare patient DNA. This will lead to more advanced treatments and therapy schedules. This might even allow some cancer patients to extend their lifetime or find an individual cure. Eric thought of this idea when he noticed how quickly technology was advancing compared to medicine. Doctors have huge amounts of data collected but no generalized database to analyze and compare it together. Eric is already working to introduce Tempus to the highest trafficked hospitals in order to begin gathering and analyzing data as soon as possible. The company also has a private lab where gene-sequencing investigations will occur.Eric is no longer directly involved with Groupon, though he is still a chairman. He has channeled the majority of his focus into Tempus which he believes will be more rewarding to others. He put Kevin White, esteemed geneticist, in a top position where his expertise can have great benefit to the company.

In addition to his business endeavors, Eric also works to give back to his community and help others. Alongside his wife, Eric created the Lefkofsky Family Foundation in 2006. It is a private charity foundation that strives to assist high-impact initiatives and improves the communities it services.He is also involved in the community outside his own foundation. He serves as an adjunct professor at the University of Chicago and wrote a book called Accelerated Disruption. He is the Chairman for Chicago’s Steppenwolf Theatre Company. He is also the Trustee of Lurie Children’s Hospital of Chicago, The Museum of Science and Industry, World Business Chicago, and the Art Institute of Chicago. Eric has devoted his entire life to bettering the lives of those around him.

Eric Lefkofsky Brings In Tempus To Aid In Cancer Treatment

Eric Lefkofsky is known for his grand success with regard to GroupOn. He could have continued to bask in that glory. But he wanted to aid in the treatment of cancer.

This realization dawned on him when his wife was detected with breast cancer. This was when he started looking for information regarding diagnosis of cancer, its treatment therapies and so on. This was when he realized that even though cancer is such a common disease today, there is little information available on it. This is why doctors are not able to take informed decisions. In the end, it impacts cancer patients and their treatments. Read News Here .

This is how Tempus was born. This is an operation system that is devised keeping the cancer patients in mind. Doctors required this in order to treat their patients. But developing something like Tempus would have required scientific steps. This is where Eric played a key role. He has years of experience in building successful businesses. These are related to aggregating vast amounts of data. This data has to be mined in order get insights that can help to advance the status of given industry.

Eric Lefkofsky made Tempus which allows partnering doctors to make use of its analytics system. This lets them learn more about their patients and formulate their treatment plans accordingly.

There are a number of health centers that are collaborating with Tempus in order to make use of it. One of these is the Abramson Cancer Center at the University of Pennsylvania. There are a number of local hospitals that have teamed up with Tempus. This includes the Lurie Comprehensive Cancer Center of the Northwestern University. Another is the Rush University Medical Center. There is a clinical trial group which is at the University of Chicago. Even this has teamed up with Tempus to make use of its data and services.

Lefkofsky is well aware that it is a long journey. There will be no quick results here. But he says that it will be an exciting journey. This is because he is getting technology to cancer and healthcare.

http://www.chicagobusiness.com/article/20161001/ISSUE01/310019995/can-eric-lefkofsky-save-your-life for more .

Cancer Treatment Centers of American Pushes Dynamic New Plan

Cancer Treatment Centers of America has collaborated with NantHealth and Allscripts to form the Clinical Pathways custom communications plan. The Clinical Pathways will link up all processes and research statistics available for use by all parts of a cancer treatment plan that is implemented for an individual who is undergoing treatment at Cancer Treatment Centers of America, CTCA.

The entire program has been designed with the patient in mind as it makes the latest research in the cancer arena available along with various treatments and therapies that go along with specific remedies.

The focus is to create a great deal of transparency for patients and family while at the same time helping to reduce random guesswork by revealing all of the current research on one platform that is as up-to-date as possible. There is enough information from focused studies and treatments to allow care teams to contrast and compare different treatment paths to analyze treatments based on the diagnosis.

Clinical Pathways also provides a robust amount of detail to the point that insurance companies can secure data in enough detail so that claims can be decided with more dispatch because all the needed information will be found in one place.

Physicians and caregivers will be able to access information from an unbiased Evidence-Based Medical Library which contains over 2,700 regimens for treatment that cover just about every cancer that exists. The database is maintained by a full-time group of oncologists and other professionals who keep the database updated with the most recent results of studies and outcomes.

As stated on Wikipedia, Cancer Treatment Centers of America operate out of five different hospitals that compromise a national network of outreach for varying treatment for adult cancer patients. Supported therapies include all of the well-known programs of chemotherapy, radiation, surgery, Immunotherapy, genomic testing, and others. Other experimental therapies and treatments are having to do with diet and other evidenced supported therapies are also used.

For more information please for Cancer Treatment Centers of America on Facebook.